AxoGen(us:AXGN)

    15.64

    +5.32%

    Updated on 2024-12-22

    Open:14.66
    Close:15.64
    High:15.89
    Low:14.54
    Pre Close:14.85
    Volume:1.10M
    Amount:17.12M
    Turnover:2.50%
    Shares:44.01M
    MarketCap:688.29M
    DateTotalTotal SharesTotal RatioNewIncreasedDecreased
    2024-06-301363523305080.40%184747
    2024-03-311323357555676.85%133855
    2023-12-311423230896274.92%243559
    2023-09-301423209053474.56%115260
    2023-06-301443191373574.25%176140
    2023-03-311453144516873.45%134655
    2022-12-311463095190472.92%225048
    2022-09-301343222744776.24%224046
    dateorgNametotalratiochangeShareschangeRatio
    2024-03-31Arrowmark Colorado Holdings Llc472672010.82%-425580-8.26%
    2024-03-31Blackrock Inc.32322077.40%-110566-3.31%
    2024-03-31Morgan Stanley31805787.28%981413.18%
    2024-03-31Soleus Capital Management, L.P.31058157.11%51000019.65%
    2024-03-31Vanguard Group Inc24114035.52%-54093-2.19%
    2024-03-31Perceptive Advisors Llc15539293.56%74554992.23%
    2024-03-31Millennium Management Llc13161463.01%-172574-11.59%
    2024-03-31Dafna Capital Management Llc9358942.14%0
    2024-03-31Geode Capital Management, Llc9308102.13%344743.85%
    2024-03-31State Street Corp7990511.83%69640.88%

    About

    Axogen, Inc. engages in the development and market of surgical solutions for peripheral nerve regeneration and repair. It also provides products and education to improve surgical treatment algorithms for peripheral nerve damage or discontinuity. The firm’s products include avance nerve graft, axoguard nerve connector, axoguard nerve protector, avive soft tissue membrane, acroval neurosensory and motor testing system, and axotouch two-point discriminator. The company was founded in 1977 and is headquartered in Alachua, FL.
    Address:13631 Progress Boulevard,Suite 400

    Market Movers